Skip to main content
TipRanks
Go Ultimate75% OFF

Evgen Pharma (TCF) Stock Statistics & Valuation Metrics

4 Followers

Total Valuation

Evgen Pharma has a market cap or net worth of GBX 4.64M. The enterprise value is GBX 2.66M.

Market Cap
GBX 4.64M
Enterprise Value
GBX 2.66M

Share Statistics

Evgen Pharma has 2,732,297,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
2,732,297,000
Owned by Insiders
23.41%
Owned by Institutions
―

Financial Efficiency

Evgen Pharma’s return on equity (ROE) is -1.30 and return on invested capital (ROIC) is -116.18%.

Return on Equity (ROE)
-1.30
Return on Assets (ROA)
-0.73
Return on Invested Capital (ROIC)
-116.18%
Return on Capital Employed (ROCE)
-1.18
Revenue Per Employee
0
Profits Per Employee
-392.33K
Employee Count
9
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Evgen Pharma is -1.65. Evgen Pharma’s PEG ratio is -0.02.

PE Ratio
-1.65
PS Ratio
0.00
PB Ratio
1.35
Price to FCF
-1.38
Price to Operating Cash Flow
-1.44
PEG Ratio
-0.02

Income Statement

In the last 12 months, Evgen Pharma had revenue of 0 and earned -3.53M in profits. Earnings per share was -0.00.

Revenue
0
Gross Profit
-16.00K
Operating Income
-3.69M
Pretax Income
-3.57M
Net Income
-3.53M
EBITDA
-3.67M
Earnings Per Share (EPS)
-0.00

Cash Flow

In the last 12 months, operating cash flow was -2.55M and capital expenditures -17,000, giving a free cash flow of -2.56M billion.

Operating Cash Flow
-2.55M
Free Cash Flow
-2.56M
Free Cash Flow per Share
-0.00

Dividends & Yields

Evgen Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-72.31%
Earnings Yield
-96.48%

Stock Price Statistics

Beta
0.88
52-Week Price Change
-21.43%
50-Day Moving Average
0.18
200-Day Moving Average
0.20
Relative Strength Index (RSI)
25.79
Average Volume (3m)
2.81M

Important Dates

Evgen Pharma upcoming earnings date is Dec 09, 2026, TBA (Not Confirmed).

Last Earnings Date
Jun 10, 2026
Next Earnings Date
Dec 09, 2026
Ex-Dividend Date
―

Financial Position

Evgen Pharma as a current ratio of 1.36, with Debt / Equity ratio of 0.40%

Current Ratio
1.36
Quick Ratio
1.36
Debt to Market Cap
0.00
Net Debt to EBITDA
0.13
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Evgen Pharma has paid -37.00K in taxes.

Income Tax
-37.00K
Effective Tax Rate
0.01

Enterprise Valuation

Evgen Pharma EV to EBITDA ratio is -0.85, with an EV/FCF ratio of -1.20.

EV to Sales
0.00
EV to EBITDA
-0.85
EV to Free Cash Flow
-1.20
EV to Operating Cash Flow
-1.21

Balance Sheet

Evgen Pharma has GBX 1.54M in cash and marketable securities with GBX 11.00K in debt, giving a net cash position of GBX 1.53M billion.

Cash & Marketable Securities
GBX 1.54M
Total Debt
GBX 11.00K
Net Cash
GBX 1.53M
Net Cash Per Share
GBX 0.00
Tangible Book Value Per Share
GBX 0.00

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Evgen Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
―
EPS Growth Forecast
55.56%

Scores

Smart Score
―
AI Score
42